Pfizer To Allow Its COVID Pill To Be , Made and Sold for a Cheaper Price , in Poorer Countries.
On Nov. 16, Pfizer announced it had signed a licensing agreement with the U.N.-backed Medicines Patent..
Credit: Wibbitz Top Stories Duration: 01:30Published